Literature DB >> 10099848

How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence.

M Ferrari1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10099848     DOI： 10.1177/0333102499019s2302

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  9 in total

Review 1.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Authors:  P Tfelt-Hansen; P De Vries; P R Saxena
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Assessing the efficacy of drugs for the acute treatment of migraine: issues in clinical trial design.

Authors:  Nabih M Ramadan
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Acute Treatment of Migraine.

Authors:  Vesile Öztürk
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 4.  [Clinical use of triptans in the management of migraine].

Authors:  Michel Lantéri-Minet
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Headache Recurrence and Treatment.

Authors:  Sheena K. Aurora; John Dempsey
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

Review 6.  Rizatriptan: an update of its use in the management of migraine.

Authors:  Keri Wellington; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  WITHDRAWN: Rizatriptan for acute migraine.

Authors:  A D Oldman; L A Smith; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 8.  WITHDRAWN: Eletriptan for acute migraine.

Authors:  L A Smith; A D Oldman; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

9.  Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Authors:  Hans-Christoph Diener; Cristina Tassorelli; David W Dodick; Stephen D Silberstein; Richard B Lipton; Messoud Ashina; Werner J Becker; Michel D Ferrari; Peter J Goadsby; Patricia Pozo-Rosich; Shuu-Jiun Wang; Jay Mandrekar
Journal:  Cephalalgia       Date:  2019-02-26       Impact factor: 6.292
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.